Metabolic Brain Disease

, Volume 31, Issue 2, pp 395–404 | Cite as

Satureja bachtiarica ameliorate beta-amyloid induced memory impairment, oxidative stress and cholinergic deficit in animal model of Alzheimer’s disease

  • Maliheh Soodi
  • Soodabeh Saeidnia
  • Mohammad Sharifzadeh
  • Homa Hajimehdipoor
  • Abolfazl Dashti
  • Mohammad Reza Sepand
  • Shahla Moradi
Original Article


Extracellular deposition of Beta-amyloid peptide (Aβ) is the main finding in the pathophysiology of Alzheimer’s disease (AD), which damages cholinergic neurons through oxidative stress and reduces the cholinergic neurotransmission. Satureja bachtiarica is a medicinal plant from the Lamiaceae family which was widely used in Iranian traditional medicine. The aim of the present study was to investigate possible protective effects of S. bachtiarica methanolic extract on Aβ induced spatial memory impairment in Morris Water Maze (MWM), oxidative stress and cholinergic neuron degeneration. Pre- aggregated Aβ was injected into the hippocampus of each rat bilaterally (10 μg/rat) and MWM task was performed 14 days later to evaluate learning and memory function. Methanolic extract of S.bachtiarica (10, 50 and 100 mg/Kg) was injected intraperitoneally for 19 consecutive days, after Aβ injection. After the probe test the brain tissue were collected and lipid peroxidation, Acetylcholinesterase (AChE) activity and Cholin Acetyl Transferees (ChAT) immunorectivity were measured in the hippocampus. Intrahipocampal injection of Aβ impaired learning and memory in MWM in training days and probe trail. Methanolic extract of S. bachtiarica (50 and 100 mg/Kg) could attenuate Aβ-induced memory deficit. ChAT immunostaining revealed that cholinergic neurons were loss in Aβ- injected group and S. bachtiarica (100 mg/Kg) could ameliorate Aβ- induced ChAT reduction in the hippocampus. Also S. bachtiarica could ameliorate Aβ-induced lipid peroxidation and AChE activity increase in the hippocampus. In conclusion our study represent that S.bachtiarica methanolic extract can improve Aβ-induced memory impairment and cholinergic loss then we recommended this extract as a candidate for further investigation in treatment of AD.


Alzheimer’s disease Beta amyloid peptide Satureja bachtiarica ChAT Oxidative stress Memory 



The Author wish to thank Tehran University of Medical Sciences and Health Services Grant No. 9108.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. Ahanjan M, Ghaffari J, Mohammadpour G, Nasrolahie M, Haghshenas MR, Mirabi AM (2011) Antibacterial activity of Satureja bakhtiarica bung essential oil against some human pathogenic bacteria. Afr J Microbiol Res 5:4764–4768Google Scholar
  2. Alkam T, Nitta A, Mizoguchi H, Itoh A, Nabeshima T (2007) A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by abeta(25–35). Behav Brain Res 180:139–145CrossRefPubMedGoogle Scholar
  3. Azami K, Etminani M, Tabrizian K, Salar F, Belaran M, Hosseini A, Hosseini-Sharifabad A, Sharifzadeh M (2010) The quantitative evaluation of cholinergic markers in spatial memory improvement induced by nicotine–bucladesine combination in rats. Eur J Pharmacol 636:102–107CrossRefPubMedGoogle Scholar
  4. Bai X, Zhang X, Chen L, Zhang J, Zhang L, Zhao X, Zhao T, Zhao Y (2014) Protective effect of naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-kappaB, MMP-9 and up-regulated claudin-5 expression. Neurochem Res 39:1405–1415CrossRefPubMedGoogle Scholar
  5. Balali P, Soodi M, Saeidnia S (2012) Protective effects of some medicinal plants from Lamiaceae family against beta-amyloid induced toxicity in PC12 cell. Tehran Univ Med J (TUMJ) 70:402–409Google Scholar
  6. Birks J (2006) Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev 25Google Scholar
  7. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMedGoogle Scholar
  8. Butterfield DA (1997) Beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer’s disease. Chem Res Toxicol 10:495–506CrossRefPubMedGoogle Scholar
  9. Camilleri A, Zarb C, Caruana M, Ostermeier U, Ghio S, Hogen T, Schmidt F, Giese A, Vassallo N (2013) Mitochondrial membrane permeabilisation by amyloid aggregates and protection by polyphenols. Biochim Biophys Acta 11:28Google Scholar
  10. Campanari ML, Garcia-Ayllon MS, Blazquez-Llorca L, Luk WK, Tsim K, Saez-Valero J (2014) Acetylcholinesterase protein level is preserved in the Alzheimer’s brain. J Mol Neurosci 53:446–453CrossRefPubMedGoogle Scholar
  11. Carter J, Lippa CF (2001) Beta-amyloid, neuronal death and Alzheimer’s disease. Curr Mol Med 1:733–737CrossRefPubMedGoogle Scholar
  12. Cavallucci V, D’amelio M, Cecconi F (2012) Abeta toxicity in Alzheimer’s disease. Mol Neurobiol 45:366–378CrossRefPubMedGoogle Scholar
  13. Chen Z, Zhong C (2014) Oxidative stress in Alzheimer’s disease. Neurosci Bull 30:271–281CrossRefPubMedGoogle Scholar
  14. Cheng HY, Hsieh MT, Tsai FS, Wu CR, Chiu CS, Lee MM, Xu HX, Zhao ZZ, Peng WH (2010) Neuroprotective effect of luteolin on amyloid beta protein (25–35)-induced toxicity in cultured rat cortical neurons. Phytother Res 24:S102–S108CrossRefPubMedGoogle Scholar
  15. Choi SH, Hur JM, Yang EJ, Jun M, Park HJ, Lee KB, Moon E, Song KS (2008) Beta-secretase (BACE1) inhibitors from Perilla frutescens var. acuta. Arch Pharm Res 31:183–187CrossRefPubMedGoogle Scholar
  16. Chtourou Y, Fetoui H, Gdoura R (2014) Protective effects of naringenin on iron-overload-induced cerebral cortex neurotoxicity correlated with oxidative stress. Biol Trace Elem Res 158:376–383CrossRefPubMedGoogle Scholar
  17. Contestabile A (2002) Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro. Cerebellum 1:41–55CrossRefPubMedGoogle Scholar
  18. Dashti A, Soodi M, Amani N (2014) Cr (VI) induced oxidative stress and toxicity in cultured cerebellar granule neurons at different stages of development and protective effect of Rosmarinic acid. Environ Toxicol 12:22041Google Scholar
  19. Ellman GL, Courtney KD, Andres Jr V, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95CrossRefPubMedGoogle Scholar
  20. Garcia-Ayllon MS, Small DH, Avila J, Saez-Valero J (2011) Revisiting the role of acetylcholinesterase in Alzheimer’s disease: cross-talk with P-tau and beta-amyloid. Front Mol Neurosci 4:1–9CrossRefGoogle Scholar
  21. Ghahremanitamadon F, Shahidi S, Zargooshnia S, Nikkhah A, Ranjbar A, Soleimani Asl S (2014) Protective effects of Borago officinalis extract on amyloid beta-peptide(25–35)-induced memory impairment in male rats: a behavioral study. Biomed Res Int 798535:11Google Scholar
  22. Hajimehdipoor H, Ajani AGY, Saeidnia S (2014a) Comparative study of the total phenol content and antioxidant activity of some medicinal herbal extracts. Res J Pharmacognosy 1:21–25Google Scholar
  23. Hajimehdipoor H, Mosaddegh M, Naghibi F, Haeri A, Hamzeloo-Moghadam M (2014b) Natural sesquiterpen lactones as acetylcholinesterase inhibitors. An Acad Bras Cienc 86(2):801–805CrossRefGoogle Scholar
  24. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356CrossRefPubMedGoogle Scholar
  25. Heo JH, Hyon L, Lee KM (2013) The possible role of antioxidant vitamin C in Alzheimer’s disease treatment and prevention. Am J Alzheimers Dis Other Demen 28:120–125CrossRefPubMedGoogle Scholar
  26. Hosseini-Sharifabad A, Mohammadi-Eraghi S, Tabrizian K, Soodi M, Khorshidahmad T, Naghdi N, Abdollahi M, Beyer C, Roghani A, Sharifzadeh M (2011) Effects of training in the Morris water maze on the spatial learning acquisition and VAChT expression in male rats. DARU, J Pharm Sci 19:166–172Google Scholar
  27. Howes MJ, Houghton PJ (2012) Ethnobotanical treatment strategies against Alzheimer’s disease. Curr Alzheimer Res 9:67–85CrossRefPubMedGoogle Scholar
  28. Iuvone T, De Filippis D, Esposito G, D’amico A, Izzo AA (2006) The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J Pharmacol Exp Ther 317:1143–1149CrossRefPubMedGoogle Scholar
  29. Kar S, Slowikowski SP, Westaway D, Mount HT (2004) Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer’s disease. J Psychiatry Neurosci 29:427–441PubMedPubMedCentralGoogle Scholar
  30. Khodabakhsh A, Gohari A, Davood A, Saeidnia S, Thesis, 1388–1389 (2010). Phytochemical Investigation of Satureja bachtiarica. Pharm.D, Islamic Azad university of TehranGoogle Scholar
  31. Kramer D, Minichiello L (2010) Cell culture of primary cerebellar granule cells. Methods Mol Biol 633:233–239CrossRefPubMedGoogle Scholar
  32. Liu R, Meng F, Zhang L, Liu A, Qin H, Lan X, Li L, Du G (2011) Luteolin isolated from the medicinal plant Elsholtzia rugulosa (Labiatae) prevents copper-mediated toxicity in beta-amyloid precursor protein Swedish mutation overexpressing SH-SY5Y cells. Molecules 16:2084–2096CrossRefPubMedGoogle Scholar
  33. Lleo A, Greenberg SM, Growdon JH (2006) Current pharmacotherapy for Alzheimer’s disease. Annu Rev Med 57:513–533CrossRefPubMedGoogle Scholar
  34. Luquin MR, Martinez-Vila E, Saldise L (1997) Mechanisms of cell death in Alzheimer’s disease. Rev Med Univ Navarra 41:34–45PubMedGoogle Scholar
  35. Manayi A, Mirnezami T, Saeidnia S, Ajani Y (2012) Pharmacognostical evaluation, phytochemical analysis and antioxidant activity of the roots of Achillea tenuifolia LAM. Pharmacogn J 4:14–19CrossRefGoogle Scholar
  36. Mohammadpour G, Marzony ET, Farahmand M (2012) Evaluation of the anti-Leishmania major activity of Satureja bakhtiarica essential oil in vitro. Nat Prod Commun 7:133–136PubMedGoogle Scholar
  37. Naghibi F, Mosaddegh M, Motamed SM, Ghorbani A (2005) Labiatae family in folk medicine in Iran: from ethnobotany to pharmacology. IJPR 2:63–79Google Scholar
  38. Orhan IE, Senol FS, Sener B (2012) Recent approaches towards selected lamiaceae plants for their prospective use in neuroprotection. Stud Nat Prod Chem 38:397–415CrossRefGoogle Scholar
  39. Pandey KB, Rizvi SI (2009) Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Med Cell Longev 2:270–278CrossRefGoogle Scholar
  40. Parks JK, Smith TS, Trimmer PA, Bennett Jr JP, Parker Jr WD (2001) Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro. J Neurochem 76:1050–1056CrossRefPubMedGoogle Scholar
  41. Paxinos G, Watson C (eds) (1997) The rat brain in stereotaxic coordinates. Academic Press, San DiegoGoogle Scholar
  42. Perry E, Howes MJ (2011) Medicinal plants and dementia therapy: herbal hopes for brain aging? CNS Neurosci Ther 17:683–698CrossRefPubMedGoogle Scholar
  43. Schliebs R, Arendt T (2006) The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease. J Neural Transm 113:1625–1644CrossRefPubMedGoogle Scholar
  44. Sepand MR, Soodi M, Hajimehdipoor H, Sahraei E (2013) Comparison of neuroprotective effects of melissa officinalis total extract and its acidic and non-acidic fractions against A β-induced toxicity. Iran J Pharm Res 12:415–423PubMedPubMedCentralGoogle Scholar
  45. Singhal AK, Naithani V, Bangar OP (2012) Medicinal plants with a potential to treat Alzheimer and associated symptoms. Int J Nutr Pharmacol Neurol Dis 2:84–91Google Scholar
  46. Soodi M, Sharifzadeh M, Naghdi N, Ostad N, Abdollahi M, Roghani A (2007) Systemic and developmental exposure to lead causes spatial memory deficits and a reduction in COX-2 immunoreactivity in the hippocampus of male rats. J Neurosci Res 85:3183–3192CrossRefPubMedGoogle Scholar
  47. Soodi M, Naghdi N, Hajimehdipoor H, Choopani S, Sahraei E (2014) Memory-improving activity of Melissa officinalis extract in naïve and scopolamine-treated rats. Res Pharm Sci 9:107–114PubMedPubMedCentralGoogle Scholar
  48. Stepanichev MY, Zdobnova IM, Zarubenko II, Moiseeva YV, Lazareva NA, Onufriev MV, Gulyaeva NV (2004) Amyloid-beta(25–35)-induced memory impairments correlate with cell loss in rat hippocampus. Physiol Behav 80:647–655CrossRefPubMedGoogle Scholar
  49. Sun MK, Alkon DL (2002) Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by beta-amyloid(25–35). J Neurophysiol 87:2441–2449PubMedGoogle Scholar
  50. Tayeb HO, Yang HD, Price BH, Tarazi FI (2012) Pharmacotherapies for Alzheimer’s disease: beyond cholinesterase inhibitors. Pharmacol Ther 134:8–25CrossRefPubMedGoogle Scholar
  51. Tepe B (2015) Inhibitory effect of Satureja on certain types of organisms. Rec Nat Prod 9:1–18Google Scholar
  52. Topcu G, Kusman T (2014) Lamiaceae family plants as a potential anticholinesterase source in the treatment ofAlzheimer’s disease. Bezmialem Science 1:1–25CrossRefGoogle Scholar
  53. Tsai FS, Cheng HY, Hsieh MT, Wu CR, Lin YC, Peng WH (2010) The ameliorating effects of luteolin on beta-amyloid-induced impairment of water maze performance and passive avoidance in rats. Am J Chin Med 38:279–291CrossRefPubMedGoogle Scholar
  54. Vauzour D (2012) Dietary polyphenols as modulators of brain functions: biological actions and molecular mechanisms underpinning their beneficial effects. Oxidative Med Cell Longev 914273:3Google Scholar
  55. Wei H, Leeds PR, Qian Y, Wei W, Chen R, Chuang D (2000) Beta-amyloid peptide-induced death of PC 12 cells and cerebellar granule cell neurons is inhibited by long-term lithium treatment. Eur J Pharmacol 392:117–123CrossRefPubMedGoogle Scholar
  56. Yamaguchi Y, Kawashima S (2001) Effects of amyloid-beta-(25–35) on passive avoidance, radial-arm maze learning and choline acetyltransferase activity in the rat. Eur J Pharmacol 412:265–272CrossRefPubMedGoogle Scholar
  57. Yamaguchi Y, Matsuno T, Kawashima S (2002) Antiamnesic effects of azaindolizinone derivative ZSET845 on impaired learning and decreased ChAT activity induced by amyloid-beta 25–35 in the rat. Brain Res 945:259–265CrossRefPubMedGoogle Scholar
  58. Yang W, Ma J, Liu Z, Lu Y, Hu B, Yu H (2014) Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats. Neurol Sci 35:741–751CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Maliheh Soodi
    • 1
  • Soodabeh Saeidnia
    • 2
  • Mohammad Sharifzadeh
    • 3
  • Homa Hajimehdipoor
    • 4
  • Abolfazl Dashti
    • 1
  • Mohammad Reza Sepand
    • 3
  • Shahla Moradi
    • 1
  1. 1.Department of Toxicology, Faculty of Medical SciencesTarbiat Modares UniversityTehranIran
  2. 2.Medicinal Plants Research Center, Faculty of PharmacyTehran University of Medical SciencesTehranIran
  3. 3.Department of Pharmacology and Toxicology, Faculty of PharmacyTehran University of Medical SciencesTehranIran
  4. 4.Department of Traditional Pharmacy, School of Traditional MedicineShahid Beheshti University of Medical SciencesTehranIran

Personalised recommendations